Sterling Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $548K | Sell |
6,371
-906
| -12% | -$79.4K | 0.01% | 768 |
|
|
2026
Q1 | $658K | Sell |
7,277
-5,118
| -41% | -$470K | 0.01% | 646 |
|
|
2025
Q4 | $1.11M | Sell |
12,395
-4,107
| -25% | -$389K | 0.02% | 606 |
|
|
2025
Q3 | $1.63M | Sell |
16,502
-1,394
| -8% | -$138K | 0.02% | 465 |
|
|
2025
Q2 | $1.63M | Buy |
17,896
+2,237
| +14% | +$216K | 0.02% | 456 |
|
|
2025
Q1 | $1.77M | Sell |
15,659
-744
| -5% | -$79.6K | 0.03% | 398 |
|
|
2024
Q4 | $1.73M | Buy |
16,403
+2,535
| +18% | +$272K | 0.02% | 460 |
|
|
2024
Q3 | $1.5M | Buy |
+13,868
| New | +$1.51M | 0.02% | 458 |
|
|
2019
Q3 | $79.1M | Sell |
593,438
-39,199
| -6% | -$5.06M | 0.75% | 39 |
|
|
2019
Q2 | $72.3M | Sell |
632,637
-445
| -0.1% | -$52.1K | 0.7% | 51 |
|
|
2019
Q1 | $78.5M | Sell |
633,082
-43,788
| -6% | -$4.98M | 0.78% | 35 |
|
|
2018
Q4 | $68.2M | Sell |
676,870
-37,198
| -5% | -$4.18M | 0.74% | 40 |
|
|
2018
Q3 | $91.1M | Sell |
714,068
-34,627
| -5% | -$4.12M | 0.82% | 33 |
|
|
2018
Q2 | $81M | Sell |
748,695
-13,130
| -2% | -$1.43M | 0.75% | 44 |
|
|
2018
Q1 | $80.7M | Sell |
761,825
-70,008
| -8% | -$8.13M | 0.76% | 41 |
|
|
2017
Q4 | $97.5M | Sell |
831,833
-2,517
| -0.3% | -$285K | 0.88% | 26 |
|
|
2017
Q3 | $94.8M | Sell |
834,350
-440,090
| -35% | -$50.8M | 0.89% | 29 |
|
|
2017
Q2 | $159M | Sell |
1,274,440
-12,977
| -1% | -$1.54M | 1.53% | 2 |
|
|
2017
Q1 | $153M | Sell |
1,287,417
-119,144
| -8% | -$13.5M | 1.44% | 5 |
|
|
2016
Q4 | $141M | Buy |
1,406,561
+126,640
| +10% | +$13.6M | 1.27% | 6 |
|
|
2016
Q3 | $162M | Sell |
1,279,921
-8,673
| -0.7% | -$1.07M | 1.49% | 3 |
|
|
2016
Q2 | $151M | Sell |
1,288,594
-57,450
| -4% | -$6.5M | 1.38% | 5 |
|
|
2016
Q1 | $139M | Sell |
1,346,044
-3,494
| -0.3% | -$338K | 1.27% | 6 |
|
|
2015
Q4 | $134M | Buy |
1,349,538
+40,632
| +3% | +$3.98M | 1.19% | 9 |
|
|
2015
Q3 | $119M | Buy |
1,308,906
+454,099
| +53% | +$45.5M | 1.07% | 11 |
|
|
2015
Q2 | $90.7M | Buy |
854,807
+288,114
| +51% | +$31.9M | 0.82% | 42 |
|
|
2015
Q1 | $64.7M | Buy |
566,693
+4,206
| +0.7% | +$480K | 0.58% | 70 |
|
|
2014
Q4 | $61.9M | Sell |
562,487
-27,727
| -5% | -$2.92M | 0.54% | 70 |
|
|
2014
Q3 | $57.6M | Buy |
590,214
+2,586
| +0.4% | +$254K | 0.7% | 45 |
|
|
2014
Q2 | $59.3M | Sell |
587,628
-21,621
| -4% | -$2.11M | 0.51% | 79 |
|
|
2014
Q1 | $55.9M | Buy |
609,249
+9,173
| +2% | +$845K | 0.48% | 86 |
|
|
2013
Q4 | $54.3M | Buy |
600,076
+43,252
| +8% | +$3.74M | 0.5% | 87 |
|
|
2013
Q3 | $44.4M | Buy |
556,824
+14,600
| +3% | +$1.15M | 0.52% | 84 |
|
|
2013
Q2 | $39.5M | Buy |
+542,224
| New | +$40.5M | 0.49% | 86 |
|
Other funds holding ZBH
Sterling Capital Management's ZBH Position: Q2 2026 in Review
Sterling Capital Management reduced its Zimmer Biomet (ZBH) stake by 12% in Q2 2026, selling an estimated $79.4K and leaving 6,371 shares worth $548K. The position accounts for 0.01% of the portfolio, ranked #768.
Sterling Capital Management first reported a position in ZBH in Q2 2013 and has held it in 34 quarters since. The position peaked at $162M in Q3 2016. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Sterling Capital Management held 6,371 shares of Zimmer Biomet worth $548K as of Q2 2026.
- Sterling Capital Management sold 906 Zimmer Biomet shares in Q2 2026, an estimated $79.4K.
- Zimmer Biomet made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #768 holding.
- Sterling Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 34 quarters since.
- Sterling Capital Management's Zimmer Biomet position peaked at $162M in Q3 2016.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.